Annual CFI
$11.70 K
+$595.90 K+102.00%
31 December 2023
Summary:
Enveric Biosciences annual cash flow from investing activities is currently $11.70 thousand, with the most recent change of +$595.90 thousand (+102.00%) on 31 December 2023. During the last 3 years, it has risen by +$55.80 thousand (+126.53%). ENVB annual CFI is now -99.47% below its all-time high of $2.19 million, reached on 31 December 2021.ENVB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Enveric Biosciences quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.ENVB quarterly CFI is now -100.00% below its all-time high of $3.69 million, reached on 30 September 2015.ENVB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Enveric Biosciences TTM cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$5500.00 (-100.00%). ENVB TTM CFI is now -100.00% below its all-time high of $2.60 million, reached on 30 September 2015.ENVB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +102.0% | 0.0% | -100.0% |
| 3 y3 years | +126.5% | -100.0% | -100.0% |
| 5 y5 years | +100.3% | 0.0% | +100.0% |
ENVB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.5% | +102.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| 5 y | 5 years | -99.5% | +100.3% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -99.5% | +100.2% | -100.0% | +100.0% | -100.0% | +100.0% |
Enveric Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $16.90 K(+44.4%) |
| Dec 2023 | $11.70 K(-102.0%) | $0.00(0.0%) | $11.70 K(+112.7%) |
| Sept 2023 | - | $0.00(-100.0%) | $5500.00(-142.0%) |
| June 2023 | - | $16.90 K(-425.0%) | -$13.10 K(-84.4%) |
| Mar 2023 | - | -$5200.00(-16.1%) | -$83.90 K(-85.6%) |
| Dec 2022 | -$584.20 K(-126.7%) | -$6200.00(-66.7%) | -$584.20 K(-23.9%) |
| Sept 2022 | - | -$18.60 K(-65.5%) | -$767.70 K(-133.3%) |
| June 2022 | - | -$53.90 K(-89.3%) | $2.31 M(-2.3%) |
| Mar 2022 | - | -$505.50 K(+166.5%) | $2.36 M(+7.7%) |
| Dec 2021 | $2.19 M(-5067.3%) | -$189.70 K(-106.2%) | $2.19 M(-6.2%) |
| Sept 2021 | - | $3.06 M(>+9900.0%) | $2.34 M(-424.9%) |
| June 2021 | - | $0.00(-100.0%) | -$719.10 K(+6.4%) |
| Mar 2021 | - | -$675.00 K(+1430.6%) | -$675.70 K(+1432.2%) |
| Dec 2020 | -$44.10 K(-84.5%) | -$44.10 K(<-9900.0%) | -$44.10 K(-22.1%) |
| Sept 2020 | - | $0.00(-100.0%) | -$56.60 K(0.0%) |
| June 2020 | - | $43.40 K(-200.0%) | -$56.60 K(-73.8%) |
| Mar 2020 | - | -$43.40 K(-23.3%) | -$215.80 K(-24.1%) |
| Dec 2019 | -$284.30 K(-92.2%) | -$56.60 K(<-9900.0%) | -$284.30 K(+35.6%) |
| Sept 2019 | - | $0.00(-100.0%) | -$209.70 K(-92.5%) |
| June 2019 | - | -$115.80 K(+3.5%) | -$2.78 M(+3.8%) |
| Mar 2019 | - | -$111.90 K(-721.7%) | -$2.68 M(-26.3%) |
| Dec 2018 | -$3.64 M(+2042.0%) | $18.00 K(-100.7%) | -$3.64 M(-3.3%) |
| Sept 2018 | - | -$2.57 M(>+9900.0%) | -$3.76 M(+216.4%) |
| June 2018 | - | -$13.90 K(-98.7%) | -$1.19 M(+1.4%) |
| Mar 2018 | - | -$1.07 M(+905.0%) | -$1.17 M(+590.4%) |
| Dec 2017 | -$169.90 K(-97.4%) | -$106.40 K(<-9900.0%) | -$169.90 K(-86.1%) |
| Sept 2017 | - | $0.00(-100.0%) | -$1.22 M(-63.8%) |
| June 2017 | - | $2700.00(-104.1%) | -$3.38 M(-31.0%) |
| Mar 2017 | - | -$66.20 K(-94.3%) | -$4.89 M(-25.8%) |
| Dec 2016 | -$6.59 M(+259.0%) | -$1.16 M(-46.3%) | -$6.59 M(+21.3%) |
| Sept 2016 | - | -$2.15 M(+42.5%) | -$5.43 M(-1432.3%) |
| June 2016 | - | -$1.51 M(-14.4%) | $407.90 K(-50.9%) |
| Mar 2016 | - | -$1.77 M(-147.9%) | $830.20 K(-68.0%) |
| Dec 2015 | -$1.84 M(-283.6%) | - | - |
| Sept 2015 | - | $3.69 M(-438.3%) | $2.60 M(-338.3%) |
| June 2015 | - | -$1.09 M(<-9900.0%) | -$1.09 M(<-9900.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2009 | - | $0.00(0.0%) | $1.00 M(0.0%) |
| Dec 2008 | $1.00 M | $0.00(0.0%) | $1.00 M(0.0%) |
| Sept 2008 | - | $0.00(-100.0%) | $1.00 M(+52.9%) |
| June 2008 | - | $1.00 M(>+9900.0%) | $654.10 K(-286.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $0.00(0.0%) | -$350.20 K(0.0%) |
| Dec 2007 | -$350.20 K(+2234.7%) | $0.00(-100.0%) | -$350.20 K(0.0%) |
| Sept 2007 | - | -$345.90 K(+7944.2%) | -$350.20 K(+8044.2%) |
| June 2007 | - | -$4300.00(<-9900.0%) | -$4300.00(-71.3%) |
| Mar 2007 | - | $0.00(0.0%) | -$15.00 K(0.0%) |
| Dec 2006 | -$15.00 K(+85.2%) | $0.00(0.0%) | -$15.00 K(-16.2%) |
| Sept 2006 | - | $0.00(-100.0%) | -$17.90 K(+1.1%) |
| June 2006 | - | -$15.00 K(<-9900.0%) | -$17.70 K(+311.6%) |
| Mar 2006 | - | $0.00(-100.0%) | -$4300.00(-47.6%) |
| Dec 2005 | -$8100.00(-60.7%) | -$2900.00(-1550.0%) | -$8200.00(+34.4%) |
| Sept 2005 | - | $200.00(-112.5%) | -$6100.00(-4.7%) |
| June 2005 | - | -$1600.00(-59.0%) | -$6400.00(-56.8%) |
| Mar 2005 | - | -$3900.00(+387.5%) | -$14.80 K(-28.2%) |
| Dec 2004 | -$20.60 K(-0.5%) | -$800.00(+700.0%) | -$20.60 K(-42.5%) |
| Sept 2004 | - | -$100.00(-99.0%) | -$35.80 K(-4.8%) |
| June 2004 | - | -$10.00 K(+3.1%) | -$37.60 K(+31.5%) |
| Mar 2004 | - | -$9700.00(-39.4%) | -$28.60 K(+38.2%) |
| Dec 2003 | -$20.70 K(-78.4%) | -$16.00 K(+742.1%) | -$20.70 K(+115.6%) |
| Sept 2003 | - | -$1900.00(+90.0%) | -$9600.00(-63.1%) |
| June 2003 | - | -$1000.00(-44.4%) | -$26.00 K(+3.6%) |
| Mar 2003 | - | -$1800.00(-63.3%) | -$25.10 K(-73.8%) |
| Dec 2002 | -$95.90 K(+177.2%) | -$4900.00(-73.2%) | -$95.90 K(+0.1%) |
| Sept 2002 | - | -$18.30 K(>+9900.0%) | -$95.80 K(+20.7%) |
| June 2002 | - | -$100.00(-99.9%) | -$79.40 K(-20.4%) |
| Mar 2002 | - | -$72.60 K(+1412.5%) | -$99.70 K(+188.2%) |
| Dec 2001 | -$34.60 K(-77.8%) | -$4800.00(+152.6%) | -$34.60 K(-73.1%) |
| Sept 2001 | - | -$1900.00(-90.7%) | -$128.40 K(-18.3%) |
| June 2001 | - | -$20.40 K(+172.0%) | -$157.10 K(-4.3%) |
| Mar 2001 | - | -$7500.00(-92.4%) | -$164.20 K(+5.1%) |
| Dec 2000 | -$156.20 K(+576.2%) | -$98.60 K(+222.2%) | -$156.20 K(+171.2%) |
| Sept 2000 | - | -$30.60 K(+11.3%) | -$57.60 K(+113.3%) |
| June 2000 | - | -$27.50 K(-5600.0%) | -$27.00 K(-5500.0%) |
| Mar 2000 | - | $500.00(-100.5%) | $500.00(-100.2%) |
| Dec 1999 | -$23.10 K(-92.2%) | - | - |
| Dec 1998 | -$295.10 K(-48.3%) | -$95.10 K(<-9900.0%) | -$295.10 K(-37.4%) |
| Sept 1998 | - | $0.00(-100.0%) | -$471.10 K(-17.5%) |
| June 1998 | - | -$100.00 K(0.0%) | -$571.10 K(+21.2%) |
| Mar 1998 | - | -$100.00 K(-63.1%) | -$471.10 K(-17.5%) |
| Dec 1997 | -$571.00 K(-57.6%) | -$271.10 K(+171.1%) | -$571.10 K(+65.1%) |
| Sept 1997 | - | -$100.00 K(<-9900.0%) | -$346.00 K(0.0%) |
| June 1997 | - | $0.00(-100.0%) | -$346.00 K(-76.1%) |
| Mar 1997 | - | -$200.00 K(+334.8%) | -$1.45 M(+7.4%) |
| Dec 1996 | -$1.35 M(+573.0%) | -$46.00 K(-54.0%) | -$1.35 M(+3.5%) |
| Sept 1996 | - | -$100.00 K(-90.9%) | -$1.30 M(+8.3%) |
| June 1996 | - | -$1.10 M(+1000.0%) | -$1.20 M(+1100.0%) |
| Mar 1996 | - | -$100.00 K | -$100.00 K |
| Dec 1995 | -$200.00 K(+100.0%) | - | - |
| Dec 1994 | -$100.00 K(0.0%) | - | - |
| Aug 1994 | -$100.00 K | - | - |
FAQ
- What is Enveric Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Enveric Biosciences?
- What is Enveric Biosciences annual CFI year-on-year change?
- What is Enveric Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Enveric Biosciences?
- What is Enveric Biosciences quarterly CFI year-on-year change?
- What is Enveric Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Enveric Biosciences?
- What is Enveric Biosciences TTM CFI year-on-year change?
What is Enveric Biosciences annual cash flow from investing activities?
The current annual CFI of ENVB is $11.70 K
What is the all time high annual CFI for Enveric Biosciences?
Enveric Biosciences all-time high annual cash flow from investing activities is $2.19 M
What is Enveric Biosciences annual CFI year-on-year change?
Over the past year, ENVB annual cash flow from investing activities has changed by +$595.90 K (+102.00%)
What is Enveric Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of ENVB is $0.00
What is the all time high quarterly CFI for Enveric Biosciences?
Enveric Biosciences all-time high quarterly cash flow from investing activities is $3.69 M
What is Enveric Biosciences quarterly CFI year-on-year change?
Over the past year, ENVB quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Enveric Biosciences TTM cash flow from investing activities?
The current TTM CFI of ENVB is $0.00
What is the all time high TTM CFI for Enveric Biosciences?
Enveric Biosciences all-time high TTM cash flow from investing activities is $2.60 M
What is Enveric Biosciences TTM CFI year-on-year change?
Over the past year, ENVB TTM cash flow from investing activities has changed by -$5500.00 (-100.00%)